InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $0.680 0.005 (0.74%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$21 Investor Webinar Invitation 7 Aug 2025 10:06AM $1.085 $0.680 fallen by 37.33%
$21 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2025 5:41PM $1.130 $0.680 fallen by 39.82%
$21 Appointment and Resignation of Company Secretary 23 Jul 2025 5:40PM $1.160 $0.680 fallen by 41.38%
$21 Completion of Recruitment in TRIPP-FFX Clinical Trial 23 Jul 2025 8:27AM $1.185 $0.680 fallen by 42.62%
$21 Change in substantial holding from SOL 15 Jul 2025 5:07PM $1.110 $0.680 fallen by 38.74%
$21 Change in substantial holding from PCG 15 Jul 2025 1:44PM $1.110 $0.680 fallen by 38.74%
$21 Change in substantial shareholding from AEF 15 Jul 2025 12:52PM $1.120 $0.680 fallen by 39.29%
$21 Application for quotation of securities - OSL 15 Jul 2025 8:36AM $1.100 $0.680 fallen by 38.18%
$21 Final Director's Interest Notice 11 Jul 2025 2:00PM $1.110 $0.680 fallen by 38.74%
$21 Initial Director's Interest Notice 11 Jul 2025 1:59PM $1.120 $0.680 fallen by 39.29%
$21 OSLOD Options Range of Units and Top 20 Holders 11 Jul 2025 10:45AM $1.110 $0.680 fallen by 38.74%
$21 Application for quotation of securities - OSL 11 Jul 2025 10:45AM $1.110 $0.680 fallen by 38.74%
$21 Application for quotation of securities - OSL 11 Jul 2025 10:44AM $1.110 $0.680 fallen by 38.74%
$21 OncoSil announces appointment of Non-Executive Director 11 Jul 2025 9:44AM $1.250 $0.680 fallen by 45.60%
$21 Proposed issue of securities - OSL 9 Jul 2025 1:48PM $1.230 $0.680 fallen by 44.72%
$21 Update - Proposed issue of securities - OSL 9 Jul 2025 12:35PM $1.230 $0.680 fallen by 44.72%
$21 Update - Proposed issue of securities - OSL 9 Jul 2025 12:29PM $1.230 $0.680 fallen by 44.72%
$21 Results of Meeting 8 Jul 2025 1:03PM $1.255 $0.680 fallen by 45.82%
$21 OSL completes $2 million Share Purchase Plan 7 Jul 2025 5:06PM $1.175 $0.680 fallen by 42.13%
$21 Completion of Recruitment in PANCOSIL Study 4 Jul 2025 8:24AM $1.195 $0.680 fallen by 43.10%
$21 Becoming a substantial shareholder from AEF 26 Jun 2025 11:38AM $1.105 $0.680 fallen by 38.46%
$21 Change of Directors Interest Notice Lel Smits 25 Jun 2025 4:43PM $1.020 $0.680 fallen by 33.33%
$21 Notification of cessation of securities - OSL 19 Jun 2025 5:41PM $1.030 $0.680 fallen by 33.98%
$21 Notification regarding unquoted securities - OSL 19 Jun 2025 10:30AM $1.045 $0.680 fallen by 34.93%
$21 Change in substantial holding from SOL 18 Jun 2025 3:37PM $1.015 $0.680 fallen by 33%

101 - 125 of 780 results

Page 5 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.